...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Exempt Distribution Jan 20
4
Jan 26, 2021 06:54PM
3
Jan 30, 2021 09:09AM
3
Jan 30, 2021 09:11AM

I think someone mentioned it was the availability of shares. There might be enough shares available on the OTC vs a PP.

FWIW, I bought 1,000 shares on the OTC and it merged it with my original RVX newco shares. I know someone else said the same but just wanted to add the same happened for me.

Share
New Message
Please login to post a reply